alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
[Federal Register Volume 74, Number 74 (Monday, April 20, 2009)]
[Notices]
[Page 17993]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E9-8933]


-----------------------------------------------------------------------

DEPARTMENT OF LABOR

Employment and Training Administration

[TA-W-65,462]


Sekisui Voltek, LLC, Coldwater, MI; Notice of Termination of 
Investigation

    Pursuant to Section 221 of the Trade Act of 1974, as amended, an 
investigation was initiated on March 3, 2009 in response to a worker 
petition filed on behalf of the workers of Sekisui Voltek, LLC, 
Coldwater, Michigan.
    The petitioners requested that the petition be withdrawn. 
Consequently, the investigation has been terminated.

    Signed at Washington, DC, this 27th day of March 2009.
Richard Church,
Certifying Officer, Division of Trade Adjustment Assistance.
[FR Doc. E9-8933 Filed 4-17-09; 8:45 am]
BILLING CODE 4510-FN-P
II 

112TH CONGRESS 

2D SESSION S. 2857 

To extend the temporary suspension of duty on Paraquat dichloride (1,1′- 

dimethyl-4,4′-bipyridinium dichloride). 

IN THE SENATE OF THE UNITED STATES 

MAY 8, 2012 

Mr. PRYOR introduced the following bill; which was read twice and referred 

to the Committee on Finance 

A BILL 

To extend the temporary suspension of duty on Paraquat 

dichloride (1,1′-dimethyl-4,4′-bipyridinium dichloride). 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. PARAQUAT DICHLORIDE (1,1′-DIMETHYL-4,4′- 

4 BIPYRIDINIUM DICHLORIDE). 

5 (a) IN GENERAL.—Heading 9902.13.06 of the Har6 monized Tariff Schedule of the United States (relating to 

7 paraquat dichloride) is amended by striking the date in 

8 the effective period column and inserting ‘‘12/31/2015’’. 

9 (b) EFFECTIVE DATE.—The amendment made by 

10 subsection (a) applies with respect to goods entered, or 


tjames on DSK6SPTVN1PROD with BILLS
2 

•S 2857 IS

1 withdrawn from warehouse for consumption, on or after 

2 the 15th day after the date of the enactment of this Act. 

Æ 


tjames on DSK6SPTVN1PROD with BILLS
Julio Malachi GARCIA, Appellant, v. STATE of Florida, Appellee.

Case No. 2D16-2124

District Court of Appeal of Florida, Second District.

Opinion filed January 10, 2018

**DECISION WITHOUT PUBLISHED OPINION**

Affirmed.
II 

112TH CONGRESS 

2D SESSION S. 2844 

To suspend temporarily the duty on certain PCBTF with corrosion inhibitor. 

IN THE SENATE OF THE UNITED STATES 

MAY 8, 2012 

Mr. SCHUMER introduced the following bill; which was read twice and referred 

to the Committee on Finance 

A BILL 

To suspend temporarily the duty on certain PCBTF with 

corrosion inhibitor. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. CERTAIN PCBTF WITH CORROSION INHIBITOR. 

4 (a) IN GENERAL.—Subchapter II of chapter 99 of 

5 the Harmonized Tariff Schedule of the United States is 

6 amended by inserting in numerical sequence the following 

7 new heading: 

‘‘ 9902.01.00 1-Chloro-4-(trifluoromethyl) 

benzene (CAS No. 98–56–6) 

containing a corrosion inhibitor stabilizer (provided for in 

subheading 2903.99.08 or 

3824.90.92) ........................... Free No change No change On or before 

12/31/2015 ’’. 


jbell on DSK7SPTVN1PROD with BILLS
2 

•S 2844 IS

1 (b) EFFECTIVE DATE.—The amendment made by 

2 subsection (a) applies with respect to goods entered, or 

3 withdrawn from warehouse for consumption, on or after 

4 the 15th day after the date of the enactment of this Act. 

Æ 


jbell on DSK7SPTVN1PROD with BILLS
```

[Congressional Bills 112th Congress]
[From the U.S. Government Publishing Office]
[S. 2923 Introduced in Senate (IS)]

112th CONGRESS
  2d Session
                                S. 2923

  To suspend temporarily the duty on mixtures of Propiconazole and 3-
       iodo-2-propynol butylcarbamate and application adjuvants.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                              May 8, 2012

 Mr. Menendez introduced the following bill; which was read twice and 
                  referred to the Committee on Finance

_______________________________________________________________________

                                 A BILL

 
  To suspend temporarily the duty on mixtures of Propiconazole and 3-
       iodo-2-propynol butylcarbamate and application adjuvants.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. MIXTURES OF PROPICONAZOLE AND 3-IODO-2-PROPYNOL 
              BUTYLCARBAMATE AND APPLICATION ADJUVANTS.

    (a) In General.--Subchapter II of chapter 99 of the Harmonized 
Tariff Schedule of the United States is amended by inserting in 
numerical sequence the following new heading:

``     9902.01.00      Mixtures of (<plus- Free         No change        No change        On or before 12/  ''.
                        minus>)-                                                           31/2015.......
                        (cis+trans)-1-(2-
                        (2,4-
                        dichlorophenyl)-4-
                        propyl-1,3-
                        dioxalan-2-yl)-
                        methyl)-1H-1,2,4-
                        triazole
                        (Propiconazole)
                        (CAS No. 60207-90-
                        1), and 3-iodo-2-
                        propynol
                        butylcarbamate
                        (CAS No. 55406-53-
                        06) and
                        application
                        adjuvants
                        (provided for in
                        subheading
                        3808.92.15)......

    (b) Effective Date.--The amendment made by subsection (a) applies 
with respect to goods entered, or withdrawn from warehouse for 
consumption, on or after the 15th day after the date of the enactment 
of this Act.
                                 <all>
```
**EXHIBIT 31.1****Section 302 Certification of Principal Executive Officer**I, William T. Monahan, Chairman and Interim Chief Executive Officer of Novelis Inc. (Novelis),certify that:     1. I have reviewed this annual report on Form 10-K/A of Novelis;     2. Based on my knowledge, this report does not contain any untrue statement of amaterial fact or omit to state a material fact necessary to make the statements made, in light ofthe circumstances under which such statements were made, not misleading with respect to the periodcovered by this report;     3. Based on my knowledge, the financial statements, and other financial information includedin this report, fairly present in all material respects the financial condition, results ofoperations and cash flows of the registrant as of, and for, the periods presented in this report;     4. The registrant’s other certifying officer(s) and I are responsible forestablishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules13a-15(e) and 15d-15(e)) for the registrant and have:     a) Designed such disclosure controls and procedures, or caused such disclosure controls andprocedures to be designed under our supervision, to ensure that material information relating tothe registrant, including its consolidated subsidiaries, is made known to us by others within thoseentities, particularly during the period in which this report is being prepared;     b) Evaluated the effectiveness of the registrant’s disclosure controls and procedures andpresented in this report our conclusions about the effectiveness of the disclosure controls andprocedures, as of the end of the period covered by this report based on such evaluation; and     c) Disclosed in this report any change in the registrant’s internal control over financialreporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourthfiscal quarter in the case of an annual report) that has materially affected, or is reasonablylikely to materially affect, the registrant’s internal control over financial reporting; and     5. The registrant’s other certifying officer(s) and I have disclosed, based on ourmost recent evaluation of internal control over financial reporting, to the registrant’s auditorsand the Audit Committee of the registrant’s board of directors (or persons performing theequivalent functions):     a) All significant deficiencies and material weaknesses in the design or operation ofinternal control over financial reporting which are reasonably likely to adversely affect theregistrant’s ability to record, process, summarize and report financial information; and     b) Any fraud, whether or not material, that involves management or other employees whohave a significant role in the registrant’s internal control over financial reporting.         /s/ William T. Monahan         William T. Monahan    Chairman and Interim Chief Executive Officer    (Principal Executive Officer)Date: October 19, 2006
22
**Exhibit
      32.1**





**Certification
      of Principal Executive Officer**


**Pursuant
      to Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C
§1350)**











I,
      Lori
      A. Jones, of Analytical Surveys, Inc., certify, pursuant to Section 906 of
      the
      Sarbanes-Oxley Act of 2002, that:





(1)
      the
      Quarterly Report on Form 10-QSB for the quarterly period ended December 31,
      2006
      (the “Report”) which this statement accompanies fully complies with the
      requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934;
      and





(2)
      the
      information contained in the Report fairly presents, in all material respects,
      the financial condition and results of operations of Analytical Surveys,
      Inc.








Dated:  February
      14, 2007





/s/  Lori
      A. Jones


Lori
      A.
      Jones


Principal
      Executive Officer
Mitchell David HOLLAND, Appellant, v. STATE of Florida, Appellee.

No. 1D17-5072

District Court of Appeal of Florida, First District.

February 6, 2018 Rehearing Denied March 7, 2018

**DECISION WITHOUT PUBLISHED OPINION**

AFFIRMED.
STATE of Louisiana v. Richard Nathaniel MILLER

NO. 2018-KH-0504

Supreme Court of Louisiana.

May 11, 2018

WRIT NOT CONSIDERED. Petitioner has not demonstrated that he sought review in the court(s) below before filing in this Court nor shown the "extraordinary circumstances" that would justify bypassing that level of review. La.S.Ct.R. X § 5(b).
---

Exhibit 32.2

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, 
AS ADOPTED PURSUANT TO SECTION 906 
OF THE SARBANES-OXLEY ACT OF 2002

The undersigned, Colman Cheng, the Chief Financial Officer of CHINA NUTRIFRUIT GROUP LIMITED (the Company), DOES HEREBY CERTIFY that:

1. The Companys Quarterly Report on Form 10-Q for the quarter ended December 31, 2010 (the Report), fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934; and

2. Information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company.

IN WITNESS WHEREOF, each of the undersigned has executed this statement this 14th day of February, 2011.

/s/ Colman ChengColman Cheng 
Chief Financial Officer (Principal Financial Officer)

A signed original of this written statement required by Section 906 has been provided to China Nutrifruit Group Limited and will be retained by China Nutrifruit Group Limited and furnished to the Securities and Exchange Commission or its staff upon
request.

The forgoing certification is being furnished to the Securities and Exchange Commission pursuant to § 18 U.S.C. Section 1350. It is not being filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and is not to be
incorporated by reference into any filing of the Company, whether made before or after the date hereof, regardless of any general incorporation language in such filing.

---
##### 



EXHIBIT 32.1 CERTIFICATIONS OF CHIEF EXECUTIVE OFFICER
AND CHIEF FINANCIAL OFFICER PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 In connection with the Annual Report of Tarpon Industries, Inc. (the Company) on Form 10-K/A
(Amendment No. 1) for the year ended December 31, 2004 as filed with the Securities and Exchange
Commission on the date hereof (the Periodic Report), we, J. Peter Farquhar, Chief Executive
Officer of the Company, and James T. House, Senior Vice President and Chief Financial Officer of
the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, that:  1.
    the Periodic Report fully complies with the requirements of Section 13(a) or
15(d) of the Securities Exchange Act of 1934; and2.
    the information contained in the Periodic Report fairly presents, in all
material respects, the financial condition and results of operations of the Company. Dated: May 6, 2005
    
    /s/ J. Peter FarquharJ. Peter Farquhar, Chief Executive OfficerDated: May 6, 2005
    
    /s/ James T. HouseJames T. House, Senior Vice President andChief Financial Officer
Amendment No. 2 to the Amended and Restated Rotech Healthcare Inc.  Employees Pl



 Exhibit 10.31 
 AMENDMENT TO THE 
 ROTECH HEALTHCARE INC. EMPLOYEES PLAN 
 Amendment Number 2 to the January 1, 2003 Restatement 
 WHEREAS, Rotech Healthcare Inc. (the “Company”) established the Rotech Healthcare Inc. Employees Plan (formerly known as the Rotech Medical Corporation Employees Plan) (the “Plan”), effective
March 26, 2002; and 
 WHEREAS, the Plan was last amended and restated, in its entirety, effective January 1, 2003; and 

WHEREAS, Section 9.01 of the Plan provides that the Board of Directors of the Company (the “Board”) may amend the Plan at any time and
from time to time; and 
 WHEREAS, the Board desires to amend the Plan to provide for a two year eligibility period. 
 NOW THEREFORE, the Board hereby amends the Plan as follows: 
 FIRST: Effective January 1, 2008, a new section 1.42 is added to the Plan to read as follows: 
 1.42 Year of Service – A one-year period of employment of an Employee with an Employer or Affiliated Entity, the computation of which shall commence with the Employee’s Employment Commencement Date and
terminate with the Employee’s Separation from Service. Notwithstanding the preceding sentence, service in the Armed Forces of the United States during the period the Employer is required to give reemployment rights by law shall be counted
towards Years of Service, if an Employee returns to work with the Employer or Affiliated Entity immediately after such termination of service. 
 Notwithstanding the forgoing, Years of Service credited to a Member prior to the incurrence of a One-Year Break in Service shall be disregarded for all Plan purposes until the Member completes a Year of Service
following the occurrence of the most recent One-Year Break in Service. 
 SECOND, a new paragraph is added to the end
of Section 2.01 to read as follows: 
 Effective January 1, 2008, each Eligible Employee who is hired on or after
January 1, 2008 shall become a Member on the Entry Date that coincides with, or next follows, the completion of two (2) consecutive Years of Service. 







 THIRD: Except as herein provided, the Plan shall remain in full force and effect without further
modification. 
 IN WITNESS WHEREOF, the Board has caused this Amendment Number 2 to
be executed this 29th day of June, 2007. 
  

			
	ROTECH HEALTHCARE INC.
		
	By:	 	 



		 	Philip L. Carter
		 	President & CEO


  

 2
CERTIFICATIONS

I, Hendrik van Alphen, certify that:

1.

I have reviewed this amended annual report on Form 40-F/A of Cardero Resource Corp.;

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the issuer as of, and for, the periods presented in this report;

4.

The issuers other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the issuer and have:

(a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the issuer, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)

Evaluated the effectiveness of the issuers disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d)

Disclosed in this report any change in the issuers internal control over financial reporting that occurred during the period covered by the annual report that has materially affected, or is reasonably likely to materially affect, the issuers internal control over financial reporting; and

5.

The issuers other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the issuers auditors and the audit committee of the issuers board of directors (or persons performing the equivalent functions):

(a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the issuers ability to record, process, summarize and report financial information; and

(b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the issuers internal control over financial reporting.

Date:  April 13, 2006



/s/ Hendrik van Alphen

Hendrik van Alphen
  President and Chief Executive Officer
```

[Congressional Bills 112th Congress]
[From the U.S. Government Publishing Office]
[S. 2742 Introduced in Senate (IS)]

112th CONGRESS
  2d Session
                                S. 2742

          To suspend temporarily the duty on lanthanum oxide.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                              May 7, 2012

   Mr. Casey introduced the following bill; which was read twice and 
                  referred to the Committee on Finance

_______________________________________________________________________

                                 A BILL

 
          To suspend temporarily the duty on lanthanum oxide.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. LANTHANUM OXIDE.

    (a) In General.--Subchapter II of chapter 99 of the Harmonized 
Tariff Schedule of the United States is amended by inserting in 
numerical sequence the following new heading:

``     9902.01.00        Lanthanum oxide     Free            No change      No change      On or before     ''.
                          (CAS No. 13778-59-                                                12/31/2015
                          1) (provided for
                          in subheading
                          2846.90.80)......

    (b) Effective Date.--The amendment made by subsection (a) applies 
to goods entered, or withdrawn from warehouse for consumption, on or 
after the 15th day after the date of the enactment of this Act.
                                 <all>
```
```

[Congressional Bills 112th Congress]
[From the U.S. Government Publishing Office]
[S. 2458 Introduced in Senate (IS)]

112th CONGRESS
  2d Session
                                S. 2458

        To suspend temporarily the duty on germanium unwrought.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                             April 26, 2012

  Mr. Schumer introduced the following bill; which was read twice and 
                  referred to the Committee on Finance

_______________________________________________________________________

                                 A BILL

 
        To suspend temporarily the duty on germanium unwrought.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. GERMANIUM UNWROUGHT.

    (a) In General.--Subchapter II of chapter 99 of the Harmonized 
Tariff Schedule of the United States is amended by inserting in 
numerical sequence the following new heading:

``     9902.01.00        Germanium           Free            No change      No change      On or before     ''.
                          unwrought (CAS                                                    12/31/2015
                          No. 7440-56-4)
                          (provided for in
                          subheading
                          8112.92.60)......

    (b) Effective Date.--The amendment made by subsection (a) applies 
to goods entered, or withdrawn from warehouse for consumption, on or 
after the 15th day after the date of the enactment of this Act.
                                 <all>
```